Kimia Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Kimia Biosciences Ltd · Outcome · 13 Nov 2026, 10:12 pm
Kimia Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,681 (-21.1% YoY | +29.4% QoQ) ■ EBITDA: 458 (+81.7% YoY | +95.1% QoQ) ■ EBITDA Margin (%): 17.1 (+967 bps YoY | +575 bps QoQ) ■ PAT: 239 (+135.2% YoY | +571.1% QoQ) ■ EPS (INR): 0.50 (+138.1% YoY | +525.0% QoQ)
Original exchange filing (PDF)
More announcements from Kimia Biosciences Ltd
- Unaudited Standalone Financial Results for second quarter and half year ended 30th September 2026 along with statement of assets and liabilities and cash flows and Limited Review Report thereon. · 13 Nov 2026
- Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve to consider and approve, .... · 13 Nov 2026
- Intimation under regulation 30 of LODR Regulation - Change in Management pursuant to approval of members at 33rd Annual General Meeting of the Company. · 30 Sept 2026
- Declaration of Results of Remote E voting and Evoting at AGM held on 28.09.2026 along with Scruitiniser Report provided by Maya Sharma and Associates Company secretaries under regulation .... · 30 Sept 2026
- Submission of proceedings of the 33rd Annual General Meeting pursuant to regulations 30 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 · 28 Sept 2026
- Thirty Third Annual Report for the Financial Year 2025-2026 of Kimia Biosciences Limited · 05 Sept 2026
- Intimation of Cut off Date/ Record Date, E-Voting and AGM date for the 33rd Annual General Meeting · 05 Sept 2026
- Intimation of 33rd Annual General Meeting of the Company proposed to be held on September 28, 2026 at 03:00 P.M. through Video Conferencing/ Other Audio Visual Means. · 04 Sept 2026
